These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 29228132)
1. Vivax Malaria Chemoprophylaxis: The Role of Atovaquone-Proguanil Compared to Other Options. Meltzer E; Rahav G; Schwartz E Clin Infect Dis; 2018 May; 66(11):1751-1755. PubMed ID: 29228132 [TBL] [Abstract][Full Text] [Related]
2. A cluster of Plasmodium vivax malaria in an expedition group to Ethiopia: prophylactic efficacy of atovaquone/proguanil on liver stages of P. vivax. Mavrogordato A; Lever AM J Infect; 2012 Sep; 65(3):269-74. PubMed ID: 22609735 [TBL] [Abstract][Full Text] [Related]
3. The efficacy of chemoprophylaxis against malaria with chloroquine plus proguanil, mefloquine, and atovaquone plus proguanil in travelers from Denmark. Kofoed K; Petersen E J Travel Med; 2003; 10(3):150-4. PubMed ID: 12757688 [TBL] [Abstract][Full Text] [Related]
4. Effectiveness of short prophylactic course of atovaquone-proguanil in travelers to sub-saharan Africa. Leshem E; Meltzer E; Stienlauf S; Kopel E; Schwartz E J Travel Med; 2014; 21(2):82-5. PubMed ID: 24298915 [TBL] [Abstract][Full Text] [Related]
5. Relapsing vivax malaria after 6 months of daily atovaquone/proguanil in Afghanistan: the case for expanded use of primaquine as a causal prophylactic. Maguire JD; Llewellyn DM J Travel Med; 2007; 14(6):411-4. PubMed ID: 17995538 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of atovaquone-proguanil in treating imported malaria in Japan: the second report from the research group. Kimura M; Koga M; Kikuchi T; Miura T; Maruyama H Parasitol Int; 2012 Sep; 61(3):466-9. PubMed ID: 22484597 [TBL] [Abstract][Full Text] [Related]
7. Review: Malaria chemoprophylaxis for travelers to Latin America. Steinhardt LC; Magill AJ; Arguin PM Am J Trop Med Hyg; 2011 Dec; 85(6):1015-24. PubMed ID: 22144437 [TBL] [Abstract][Full Text] [Related]
8. Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria. McKeage K; Scott L Drugs; 2003; 63(6):597-623. PubMed ID: 12656656 [TBL] [Abstract][Full Text] [Related]
9. Drug-free Holidays: Compliance, Tolerability, and Acceptability of a 3-Day Atovaquone/Proguanil Schedule for Pretravel Malaria Chemoprophylaxis in Australian Travelers. Lau CL; Ramsey L; Mills LC; Furuya-Kanamori L; Mills DJ Clin Infect Dis; 2019 Jun; 69(1):137-143. PubMed ID: 30281083 [TBL] [Abstract][Full Text] [Related]
10. Malaria chemoprophylaxis regimens: a descriptive drug utilization study. Bloechliger M; Schlagenhauf P; Toovey S; Schnetzler G; Tatt I; Tomianovic D; Jick SS; Meier CR Travel Med Infect Dis; 2014; 12(6 Pt B):718-25. PubMed ID: 24934849 [TBL] [Abstract][Full Text] [Related]
11. Clinical implications of Plasmodium resistance to atovaquone/proguanil: a systematic review and meta-analysis. Staines HM; Burrow R; Teo BH; Chis Ster I; Kremsner PG; Krishna S J Antimicrob Chemother; 2018 Mar; 73(3):581-595. PubMed ID: 29237012 [TBL] [Abstract][Full Text] [Related]
13. Tertian malaria (Plasmodium vivax and Plasmodium ovale) in two travelers despite atovaquone-proguanil prophylaxis. Jiménez BC; Navarro M; Huerga H; López-Román E; Mendoza A; López-Vélez R J Travel Med; 2006; 13(6):373-5. PubMed ID: 17107431 [TBL] [Abstract][Full Text] [Related]
14. Atovaquone and proguanil hydrochloride for treatment of malaria. Kremsner PG; Looareesuwan S; Chulay JD J Travel Med; 1999 May; 6 Suppl 1():S18-20. PubMed ID: 23573548 [TBL] [Abstract][Full Text] [Related]
15. Atovaquone and proguanil hydrochloride: a review of nonclinical studies. Pudney M; Gutteridge W; Zeman A; Dickins M; Woolley JL J Travel Med; 1999 May; 6 Suppl 1():S8-12. PubMed ID: 23573546 [TBL] [Abstract][Full Text] [Related]
16. Randomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia. Ling J; Baird JK; Fryauff DJ; Sismadi P; Bangs MJ; Lacy M; Barcus MJ; Gramzinski R; Maguire JD; Kumusumangsih M; Miller GB; Jones TR; Chulay JD; Hoffman SL; Clin Infect Dis; 2002 Oct; 35(7):825-33. PubMed ID: 12228819 [TBL] [Abstract][Full Text] [Related]
17. Atovaquone and proguanil hydrochloride for prophylaxis of malaria. Shanks GD; Kremsner PG; Sukwa TY; van der Berg JD; Shapiro TA; Scott TR; Chulay JD; J Travel Med; 1999 May; 6 Suppl 1():S21-7. PubMed ID: 23573549 [TBL] [Abstract][Full Text] [Related]
18. Prolonged protection provided by a single dose of atovaquone-proguanil for the chemoprophylaxis of Plasmodium falciparum malaria in a human challenge model. Deye GA; Miller RS; Miller L; Salas CJ; Tosh D; Macareo L; Smith BL; Fracisco S; Clemens EG; Murphy J; Sousa JC; Dumler JS; Magill AJ Clin Infect Dis; 2012 Jan; 54(2):232-9. PubMed ID: 22052893 [TBL] [Abstract][Full Text] [Related]
19. Clinical pharmacology of atovaquone and proguanil hydrochloride. Beerahee M J Travel Med; 1999 May; 6 Suppl 1():S13-7. PubMed ID: 23573547 [TBL] [Abstract][Full Text] [Related]
20. Delayed Onset of Symptoms and Atovaquone-Proguanil Chemoprophylaxis Breakthrough by Plasmodium malariae in the Absence of Mutation at Codon 268 of pmcytb. Teo BH; Lansdell P; Smith V; Blaze M; Nolder D; Beshir KB; Chiodini PL; Cao J; Färnert A; Sutherland CJ PLoS Negl Trop Dis; 2015; 9(10):e0004068. PubMed ID: 26485258 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]